UBC Chemo is a modern hybrid-indica strain developed with a genetic background tracing back to Beauty and the Beast and Cinderellas. Reportedly, the strain is widely credited to research initiatives originating from the University of British Columbia, where the selection process focused on botanical characteristics suited for clinical applications. Cultivators can expect a moderate difficulty level when growing the plant in both indoor and outdoor environments, with a flowering phase lasting 77 days and a high yield potential.

The chemical profile is defined by a specific hierarchy of terpenes, led by myrcene as the dominant compound, followed by caryophyllene and pinene. This terpene array creates a distinct sensory experience characterized by the interplay of these three primary elements. As a THC-dominant cultivar, its aromatic and flavour qualities are shaped exclusively by this measured terpene composition.

Physiologically, the strain induces effects described as relaxed, calm, and focused. These attributes make it a frequent choice for managing pain, alleviating stress, and assisting with sleep. The genetic legacy of UBC Chemo remains significant within the breeding community, serving as a foundational parent for notable offspring such as Chemo Worx, Moon Medic OG, and the Romulan x UBC Chemo cross.